Serum Levels of Hcy, sST2 and CA-125 in CHF Patients and Their Correlation with Cardiac Function Classification
DOI:
https://doi.org/10.59958/hsf.5691Keywords:
chronic heart failure, cardiac function classification, HCY, sST2, CA-125, correlationAbstract
Background: The relationships between serum levels of homocysteine (Hcy), soluble stromelysin 2 (sST2), and tumor-associated cancer antigen 125 (CA-125) and heart failure requires further investigation. The aim of the present study was to evaluate the levels of Hcy, sST2 and CA-125 in patients with congestive heart failure and to correlate these with cardiac function, thereby providing a reference for the clinical diagnosis and treatment of heart failure. Methods: Seventy patients with chronic heart failure (CHF) diagnosed between August 2020 and July 2022 were classified into heart failure groups II (n = 25), III (n = 23) and IV (n = 22). Seventy individuals with normal physical examination results were selected as the healthy group. Serum Hcy, sST2 and CA-125 levels for all participants were evaluated and correlated with each other and with cardiac function classification. The diagnostic value of individual Hcy, sST2, CA-125 levels for CHF was evaluated, as well as a combination of these factors. Results: Hcy, sST2, and CA-125 levels were lower in the healthy group than in the heart failure group. Moreover, a progressive increase in Hcy, sST2, and CA-125 levels were observed in heart failure groups II, III, and IV. Individual Hcy, sST2 and CA-125 levels, as well as a combination of these factors, were significantly correlated with cardiac function classification (p < 0.05). Hcy, sST2 and CA-125 levels each showed diagnostic value for CHF, with the three combined having the best diagnostic value. Conclusions: Abnormally high levels of Hcy, sST2 and CA-125 occur in CHF patients and are positively correlated with cardiac function classification. Individual levels of these factors, and particularly a combination of the three, show good sensitivity and specificity for CHF diagnosis that could be widely used in clinical practice.
References
Yan Y, Ye M, Dong X, Chen Q, Hong H, Chen L, et al. Prevention of Contrast-Induced Nephropathy by Inferior Vena Cava Ultrasonography-Guided Hydration in Chronic Heart Failure Patients. Cardiology. 2021; 146: 187–194.
Li Y, Wu H, Zhang B, Xu X, Wang Y, Song Q. Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis. Medicine. 2021; 100: e26012.
Orso F, Herbst A, Migliorini M, Ghiara C, Virciglio S, Camartini V, et al. Telehealth Management and Risk Stratification of Older Patients With Chronic Heart Failure During COVID-19 Pandemic: Prognostic Evaluation of the TeleHFCovid19-Score. Journal of the American Medical Directors Association. 2022; 23: 421–427.
Reina-Couto M, Afonso J, Carvalho J, Morgado L, Ronchi FA, de Oliveira Leite AP, et al. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment. Biomedicine & Pharmacotherapy. 2021; 133: 110938.
Ping Y, Wang X, Dai Y, Wang D, Liu W, Yu P, et al. A quantitative detection of Cardiotrophin-1 in chronic heart failure by chemiluminescence immunoassay. Journal of Clinical Laboratory Analysis. 2021; 35: e23570.
Zhang Y, Fan P, Zhang H, Ma W, Song L, Wu H, et al. Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients. International Journal of Cardiology. 2021; 325: 103–108.
Lin Y, Xue Y, Liu J, Wang X, Wei L, Bai L, et al. Prognostic value of estimated plasma volume in patients with chronic systolic heart failure. Journal of Investigative Medicine. 2021; 69: 338–344.
Guan JS, Zhou Y. Analysis on the Changes and Diagnostic Value of sST2, GDF-15 and BNP Level in Patients with Chronic Heart Failure. Chinese Primary Health Care. 2018; 32: 61–64.
Yong YU. Evaluation value of sST2 and NT-ProBNP on short-term prognostic adverse events in patients with HFmrEF, HFpEF, and HFrEF. Clinical Education of General Practice. 2019;17: 792–796.
Kajimoto K, Sato N, Investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) Registry. Sex Differences in New York Heart Association Functional Classification and Survival in Acute Heart Failure Patients With Preserved or Reduced Ejection Fraction. The Canadian Journal of Cardiology. 2020; 36: 30–36.
Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. European Heart Journal. 2001; 22: 1527–1560.
Glizer SL, Shtegman OA, Petrova MM. Acute decompensation of chronic heart failure and renal dysfunction. Diagnosis and treatment. Siberian Medical Journal. 2020; 35: 35–43.
Monitillo F, Di Terlizzi V, Gioia MI, Barone R, Grande D, Parisi G, et al. Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach. Journal of Cardiovascular Development and Disease. 2020; 7: 12.
Huang XH, Lan T, Liu XJ. The BNP Testing Application in Clinical Diagnosis of Chronic Heart Failure. Chinese and Foreign Medical Research. 2017; 15: 45–46.
Farnsworth CW, Bailey AL, Jaffe AS, Scott MG. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure. Clinical Biochemistry. 2018; 59: 50–55.
Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, et al. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T. Journal of the American College of Cardiology. 2018; 72: 2309–2320.
Peng DU, Peng Y. Application of cTnT, CA125 and sST2 in diagnosis and prognosis of heart failure. International Journal of Laboratory Medicine. 2018; 39: 2300–2302.
Min LI, Jing YX, Hua-Hua LI, Yi-Xiong Z, Emergency DO, Hospital HG. Correlation analysis between sST2, NT-proBNP and cardiac function in elderly patients with COPD combined with cor pulmonale heart failure. Chinese Journal of the Frontiers of Medical Science (Electronic Version). 2017; 9: 105–109.
Guan JS, Zhou Y. Analysis on the Changes and Diagnostic Value of sST2, GDF-15 and BNP Level in Patients with Chronic Heart Failure. Chinese Primary Health Care. 2018; 32: 61–62.
